Phase III trial of infusional 5-fluorouracil/folinic acid plus oxaliplatin (FUFOX) versus capecitabine plus oxaliplatin (CAPOX) as first line treatment in advanced colorectal carcinoma (ACRC): Results of an interim safety analysis

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 3546-3546
Author(s):  
H.-T. Arkenau ◽  
H. Schmoll ◽  
S. Kubicka ◽  
T. Seufferlein ◽  
P. Reichardt ◽  
...  
Keyword(s):  
Colorectal Carcinoma ◽  
Folinic Acid ◽  
Safety Analysis ◽  
Phase Iii ◽  
Line Treatment ◽  
First Line ◽  
Phase Iii Trial ◽  
Advanced Colorectal Carcinoma ◽  
First Line Treatment

Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer

2011 ◽  
Vol 47 (2) ◽  
pp. 206-214 ◽  
Author(s):  
Ludwig Fischer von Weikersthal ◽  
Andreas Schalhorn ◽  
Martina Stauch ◽  
Detlef Quietzsch ◽  
Peter A. Maubach ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Folinic Acid ◽  
Advanced Colorectal Cancer ◽  
Phase Iii ◽  
Line Treatment ◽  
First Line ◽  
Phase Iii Trial ◽  
Acid Versus ◽  
First Line Treatment

scholarly journals Randomized phase III trial of S-1 versus capecitabine in the first-line treatment of metastatic colorectal cancer: SALTO study by the Dutch Colorectal Cancer Group

2017 ◽  
Vol 28 (6) ◽  
pp. 1288-1293 ◽  
Author(s):  
J.J.M. Kwakman ◽  
L.H.J. Simkens ◽  
J.M. van Rooijen ◽  
A.J. van de Wouw ◽  
A.J. ten Tije ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Phase Iii ◽  
Line Treatment ◽  
First Line ◽  
Phase Iii Trial ◽  
Cancer Group ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document